CORECARE GLOBAL LTDActive

Company number 08931470Private limited companyIncorporated 2014

Key figures

£1,507,568+12.6%
Net assets 2025
-8.4%
Average annual change 2020–2025
01 m2 m3 m20202021202320242025

Like most small UK companies, CORECARE GLOBAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m20202021202320242025

Dividends

from the accounts
2023

Dividends paid in the financial year: £487,867.

Filed accounts2020–2025
20202021202320242025
Turnover——4,133,015——
Profit for the year——-15,452——
Cash at bank and in hand32,607384,990206,58275,700297,562
Total assets3,658,5424,945,3377,616,6013,089,7453,523,069
Total liabilities—————
Net assets / total equity2,143,8862,270,8341,563,4881,338,4541,507,568
Average number of employees7223302020
Dividends paid——487,867——

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CORECARE GLOBAL LTD

Company

CORECARE GLOBAL LTD is a private limited company registered with Companies House under company number 08931470. It was incorporated on 10 Mar 2014. Its status is active. The registered office is in Wetherby (LS23). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Net assets were £1,507,568, up 12.6% on the previous year. Cash at bank and in hand was £297,562. The company had an average of 20 employees. Figures are available for 5 financial years (2020–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 24 Mar 2027.